SCHEMBL14564412

SCHEMBL14564412

Cc1ccc2c(CC(=O)O)nn(C)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.48
▸ KDM4C Q9H3R0 1/20 0.45
▸ KMO O15229 1/20 0.43
▸ PTGDR2 Q9Y5Y4 3/20 0.42
▸ AKR1B1 P15121 3/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NAMPT P43490 1/20 0.41
▸ POLB P06746 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ SLC22A12 Q96S37 3/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14564363 0.84 SMN1; SMN2 (0.44) MAPTKDM4CSMN1; SMN2NAMPTPOLB
SCHEMBL12984735 0.84 KMO (0.52) KDM4CKMOPTGDR2AKR1B1SLC22A12
SCHEMBL8415002 0.80 MAPT (0.54) MAPTPTGDR2AKR1B1SMN1; SMN2POLB
SCHEMBL14642050 0.76 KDM4C (0.51) KDM4CKMOSMN1; SMN2NAMPTKDM4E
SCHEMBL19215223 0.76 PTGDR2 (0.43) MAPTKMOPTGDR2SMN1; SMN2POLB
SCHEMBL14011332 0.75 PDE5A (0.39) MAPTKDM4CSMN1; SMN2NAMPTKDM4E
SCHEMBL9323969 0.75 AKR1B1 (0.51) KDM4CKMOPTGDR2AKR1B1
SCHEMBL11804 0.71 ADORA2A (0.63) KDM4CKMONAMPTMEN1KMT2A
SCHEMBL14564407 0.71 MAPT (0.50) MAPTKMOPTGDR2ALOX15SMN1; SMN2
SCHEMBL2594425 0.71 ICMT (0.43) KDM4CPTGDR2SMN1; SMN2POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070054902-A1 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists SHIONOGI & CO., LTD. (JP) 2007-03-08 — — US disclosed
US-20070054902-A1 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists SHIONOGI & CO., LTD. (JP) 2007-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054902-A1 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists NR1H3, NR1H2, RXRA MAPT 4429/4885KDM4C 3037/4885KMO 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback